These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26249121)

  • 21. Synchronous bilateral breast cancer patients treated with hypofractionated bilateral breast irradiation: A dosimetric and clinical study.
    Narasimhulu BC; Valiyaveettil D; Joseph D; Ahmed SF; Vijayakrishna E; Malik M
    J Cancer Res Ther; 2020; 16(6):1309-1313. PubMed ID: 33342789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cosmesis in patients with breast neoplasia submitted to the hypofractionated radiotherapy with of intensity-modulated beam.
    Miranda FA; Vieira MTL; Moraes FY; Marta GN; Carvalho HA; Hanna SA
    Rev Assoc Med Bras (1992); 2018 Nov; 64(11):1023-1030. PubMed ID: 30570055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
    De Rose F; Fogliata A; Franceschini D; Iftode C; D'Agostino GR; Comito T; Franzese C; Di Brina L; Clerici E; Loi M; Navarria P; Gatzemeier W; Testori A; Tinterri C; Lobefalo F; Tomatis S; Cozzi L; Scorsetti M
    Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From 25 Fractions to Five: How Hypofractionation has Revolutionised Adjuvant Breast Radiotherapy.
    Yarnold JR; Brunt AM; Chatterjee S; Somaiah N; Kirby AM
    Clin Oncol (R Coll Radiol); 2022 May; 34(5):332-339. PubMed ID: 35318945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
    Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
    J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Extreme hypofractionation: New indications for breast cancer radiotherapy].
    Bockel S; Louvel G; Brion T; Ung M; Berthelot K; Villaret F; Auzac G; Milewski C; Rivera S
    Cancer Radiother; 2021 Oct; 25(6-7):679-683. PubMed ID: 34452822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.
    Chatterjee S; Chakraborty S;
    Trials; 2020 Sep; 21(1):819. PubMed ID: 32998747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
    Franceschini D; Loi M; Chiola I; Arculeo S; Marzo M; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
    Clin Breast Cancer; 2021 Jun; 21(3):231-238. PubMed ID: 33121891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
    Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
    Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.
    Bruand M; Salleron J; Guihard S; Crety CM; Liem X; Pasquier D; Lamrani-Ghaouti A; Charra-Brunaud C; Peiffert D; Clavier JB; Desandes E; Faivre JC
    BMC Cancer; 2022 Dec; 22(1):1318. PubMed ID: 36526987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial.
    Reboucas LM; Campos CS; D'Amico GM; Lustosa AB; Fregnani JH
    Breast J; 2019 Sep; 25(5):953-957. PubMed ID: 31165541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes.
    Gadea J; Ortiz I; Roncero R; Alastuey I; Mestre F; Aymar N; Maturana JE; Garcia C; Mateu L; Pardo J
    Clin Transl Oncol; 2021 Sep; 23(9):1915-1922. PubMed ID: 33830442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast.
    Leonardi MC; Spoto R; Miglietta E; Trivellato S; La Rocca E; Luraschi R; Grosso P; De Lorenzi F; Fodor C; Dicuonzo S; Dell'Acqua V; Gerardi MA; Morra A; Francia CM; Rietjens M; Galimberti VE; Veronesi P; Orecchia R; Cattani F; Jereczek-Fossa BA
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1887-1896. PubMed ID: 31144158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
    Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
    Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal impact of the publication of guidelines and randomised evidence on the adoption of hypofractionated whole breast radiotherapy for early-stage breast cancer.
    Jung KYK; Shadbolt B; Rezo A
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):530-537. PubMed ID: 31087640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypofractionation for breast cancer: lessons learned from our neighbors to the north and across the pond.
    Eblan MJ; Vanderwalde NA; Zeman EM; Jones E
    Oncology (Williston Park); 2014 Jun; 28(6):536-46. PubMed ID: 25134333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
    Franceschini D; Fogliata A; Spoto R; Dominici L; Lo Faro L; Franzese C; Comito T; Lobefalo F; Reggiori G; Cozzi L; Sagona A; Gentile D; Scorsetti M
    Radiother Oncol; 2021 Nov; 164():50-56. PubMed ID: 34537289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Evolving Role of Whole Breast Hypofractionation in Older Patients With Early Breast Cancer.
    Kunkler I
    Semin Radiat Oncol; 2022 Apr; 32(2):155-158. PubMed ID: 35307117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review.
    Liu L; Yang Y; Guo Q; Ren B; Peng Q; Zou L; Zhu Y; Tian Y
    Radiat Oncol; 2020 Jan; 15(1):17. PubMed ID: 31952507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.